The BPA- and BPAF-driven ascended expression of and COX-2 in rat VP, as well as in human prostate cells, demonstrated that both of them hold promise as the potential interlocutors in mediating the prostatic hyperplasia disrupted by BPA and BPAF. The gene discussed is PTGS2; the disease is benign prostatic hyperplasia.